CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Friday reported third-quarter profit of $162 million.

On a per-share basis, the Cambridge, Massachusetts-based company said it had profit of 38 cents.

The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.10 per share.

The biotechnology company posted revenue of $1.31 billion in the period, also exceeding Street forecasts. Seven analysts surveyed by Zacks expected $888.8 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNA at https://www.zacks.com/ap/MRNA